Research Paper Volume 16, Issue 2 pp 1879—1896
CDK16 as a potential prognostic biomarker correlated with an immunosuppressive tumor microenvironment and benefits in enhancing the effectiveness of immunotherapy in human cancers
Figure 1. Expression of CDK16 in pan-cancer. (A) Pan-cancer expression of CDK16. (B) CDK16 expression in tumor tissues from TCGA cohort. (C) CDK16 expression in normal tissues from GTEx cohort. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.